Heart artery procedure plus drugs may boost heart function in ischemic cardiomyopathy
NCT ID NCT06930092
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two approaches for people with ischemic cardiomyopathy (weak heart muscle due to blocked arteries) and multiple blocked vessels. One group gets optimal medical therapy alone, while the other also gets a heart artery procedure (PCI) guided by imaging and pressure measurements. The goal is to see if the combination better improves the heart's pumping ability. The trial plans to enroll 158 adults with a low ejection fraction (under 40%).
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Percutaneous coronary intervention (PCI) with imaging guidance
What this could lead to
If successful, this could show that combining PCI with medication helps restore heart function more than medication alone in people with ischemic cardiomyopathy.
What could go wrong
This is a relatively small trial (158 participants) and not yet in a late phase. The benefits may be modest, and PCI carries risks like bleeding or vessel damage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC CARDIOMYOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Seoul National University Hospital
RECRUITINGSeoul, Chongno-gu, 03080, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••